Dr. Reddy's Laboratories Limited
RDY
$13.03
-$0.23-1.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -19.13% | -1.00% | 5.39% | 8.57% | 15.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.13% | -1.00% | 5.39% | 8.57% | 15.21% |
| Cost of Revenue | 0.42% | 11.10% | 18.21% | 18.15% | 23.56% |
| Gross Profit | -34.76% | -9.52% | -3.31% | 2.28% | 9.30% |
| SG&A Expenses | 5.62% | 5.83% | 10.24% | 10.18% | 14.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 54.63% | -30.02% | -28.16% | -67.63% | -99.58% |
| Total Operating Expenses | 0.02% | 6.60% | 10.91% | 12.60% | 16.52% |
| Operating Income | -93.89% | -27.37% | -13.64% | -4.69% | 10.35% |
| Income Before Tax | -90.91% | -21.94% | -8.14% | -1.35% | 20.12% |
| Income Tax Expenses | -104.68% | -28.78% | -31.93% | -1.53% | 36.19% |
| Earnings from Continuing Operations | -87.29% | -19.65% | 2.05% | -1.29% | 16.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -105.55% | 101.62% | 111.58% | -- | -- |
| Net Income | -87.36% | -18.83% | 9.86% | -0.71% | 16.99% |
| EBIT | -93.89% | -27.37% | -13.64% | -4.69% | 10.35% |
| EBITDA | -77.70% | -20.90% | -7.22% | -0.02% | 12.25% |
| EPS Basic | -87.38% | -18.77% | 9.89% | -0.65% | 16.93% |
| Normalized Basic EPS | -91.63% | -20.39% | -5.68% | 0.62% | 17.96% |
| EPS Diluted | -87.36% | -18.70% | 9.96% | -0.60% | 16.96% |
| Normalized Diluted EPS | -91.62% | -20.36% | -5.50% | 0.68% | 18.06% |
| Average Basic Shares Outstanding | 0.06% | -0.08% | -0.04% | -0.06% | 0.07% |
| Average Diluted Shares Outstanding | -0.04% | -0.13% | -0.11% | -0.12% | 0.00% |
| Dividend Per Share | -8.44% | -- | -- | -- | -4.05% |
| Payout Ratio | -- | -- | -0.13% | -- | -- |